Matches in SemOpenAlex for { <https://semopenalex.org/work/W4311700208> ?p ?o ?g. }
Showing items 1 to 58 of
58
with 100 items per page.
- W4311700208 abstract "<h3>Introduction</h3> The new revolutionary Targeted Lung Health Checks (TLHC) program in England is aimed at improving early diagnosis and survival for those diagnosed with cancer. National Lung Screening Trial in the United States showed that screening was associated with a 20% reduction in mortality from lung cancer among people with a history of heavy smoking.<sup>1</sup> <h3>Objectives and Methodology</h3> Individuals who have ever smoked and are between ages 55 to 75 years were initially invited for a free lung check and those assessed as high risk were offered a low dose computerised tomography (LDCT) scan based on which they were further referred to the fast track clinic (FTC). We analysed the data of participants referred to our FTC between August 2021 to January 2022. <h3>Results</h3> 2499 individuals completed lung health checks between Aug 2021 and Jan 2022 out of which 1295 underwent LDCT out of which 59 were suspicious of malignancy and referred to our FTC. 32 (54.23%) were diagnosed to have malignancy. Of these 28 had pathology proven lung cancer of which 15 (55.56%) were adenocarcinoma. 1 had lung metastasis from other primary and 3 were clinically considered for (SABR) treatment (1 was deemed unfit and 2 refused surgical intervention). Analysis noted a male predominance (61%) but cancer detection rate of 73.91% in females. 76.27% patients were above 65 years age. 69% had performance status of zero. 71.42% cases were early stage (1 and 2) cancers. 15.25% were found not to have malignancy. 15 (25.42%) are under CT surveillance for lung nodules. There have been 3 deaths, two due to advanced malignancy and one due to stroke. The average time from FTC to diagnosis was 58.75 days, with minimum being 5 days. <h3>Conclusion</h3> Our preliminary evaluation of the cases showed encouraging signs towards reaching the NHS long term plan target of 75% of cancers to be diagnosed in the early stages 1 and 2. Currently it is only 27% leading to a 10 year survival rate of only 10%.<sup>2</sup> Further periodic evaluation is ongoing. <h3>References</h3> <i>N Engl J Med</i> 2011;<b> 365</b>:395–409 DOI: 10.1056/nejmoa1102873 https://crukcancerintelligence.shinyapps.io/EarlyDiagnosis/" @default.
- W4311700208 created "2022-12-28" @default.
- W4311700208 creator A5026951078 @default.
- W4311700208 creator A5038229971 @default.
- W4311700208 creator A5045032569 @default.
- W4311700208 creator A5083939698 @default.
- W4311700208 creator A5091504324 @default.
- W4311700208 date "2022-11-01" @default.
- W4311700208 modified "2023-10-17" @default.
- W4311700208 title "S21 Targeted lung health check associated lung cancer fast track clinic data analysis from a major teaching hospital in Northwest UK" @default.
- W4311700208 doi "https://doi.org/10.1136/thorax-2022-btsabstracts.27" @default.
- W4311700208 hasPublicationYear "2022" @default.
- W4311700208 type Work @default.
- W4311700208 citedByCount "0" @default.
- W4311700208 crossrefType "proceedings-article" @default.
- W4311700208 hasAuthorship W4311700208A5026951078 @default.
- W4311700208 hasAuthorship W4311700208A5038229971 @default.
- W4311700208 hasAuthorship W4311700208A5045032569 @default.
- W4311700208 hasAuthorship W4311700208A5083939698 @default.
- W4311700208 hasAuthorship W4311700208A5091504324 @default.
- W4311700208 hasConcept C121608353 @default.
- W4311700208 hasConcept C126322002 @default.
- W4311700208 hasConcept C146357865 @default.
- W4311700208 hasConcept C151730666 @default.
- W4311700208 hasConcept C2776256026 @default.
- W4311700208 hasConcept C2777405583 @default.
- W4311700208 hasConcept C2777714996 @default.
- W4311700208 hasConcept C2779399171 @default.
- W4311700208 hasConcept C2781182431 @default.
- W4311700208 hasConcept C71924100 @default.
- W4311700208 hasConcept C86803240 @default.
- W4311700208 hasConceptScore W4311700208C121608353 @default.
- W4311700208 hasConceptScore W4311700208C126322002 @default.
- W4311700208 hasConceptScore W4311700208C146357865 @default.
- W4311700208 hasConceptScore W4311700208C151730666 @default.
- W4311700208 hasConceptScore W4311700208C2776256026 @default.
- W4311700208 hasConceptScore W4311700208C2777405583 @default.
- W4311700208 hasConceptScore W4311700208C2777714996 @default.
- W4311700208 hasConceptScore W4311700208C2779399171 @default.
- W4311700208 hasConceptScore W4311700208C2781182431 @default.
- W4311700208 hasConceptScore W4311700208C71924100 @default.
- W4311700208 hasConceptScore W4311700208C86803240 @default.
- W4311700208 hasLocation W43117002081 @default.
- W4311700208 hasOpenAccess W4311700208 @default.
- W4311700208 hasPrimaryLocation W43117002081 @default.
- W4311700208 hasRelatedWork W2090926117 @default.
- W4311700208 hasRelatedWork W2147367600 @default.
- W4311700208 hasRelatedWork W2591994030 @default.
- W4311700208 hasRelatedWork W2790226325 @default.
- W4311700208 hasRelatedWork W2891227487 @default.
- W4311700208 hasRelatedWork W2912715060 @default.
- W4311700208 hasRelatedWork W3080750719 @default.
- W4311700208 hasRelatedWork W3136989819 @default.
- W4311700208 hasRelatedWork W4296772914 @default.
- W4311700208 hasRelatedWork W1776799141 @default.
- W4311700208 isParatext "false" @default.
- W4311700208 isRetracted "false" @default.
- W4311700208 workType "article" @default.